Results 21 to 30 of about 16,072,038 (292)

Evaluation of non-HDL-c and total cholesterol: HDL-c ratio as cumulative marker of cardiovascular risk in diabetes mellitus

Kathmandu University Medical Journal, 2010
Also cited as vol. 8, no. 3, issue 32Background: Cardiovascular disease (CVD), is the primary cause of morbidity and mortality in patients with diabetes and have approximately - two to four times higher CVD rate than adult without diabetes.
Pokheral, B., Raut, B., Adhikari, R., Gyawali, P., Satyal, B., Aryal, M., Koju, R., Poudel, A.   +7 more
core   +5 more sources

TGL / HDL - C ratio and non-HDL-C - prognostic index in chronic kidney disease. [PDF]

Bioinformation
Dyslipidemia, a major risk factor for chronic kidney disease (CKD) affects more than ten percent of the general population. Dyslipidemia in CKD, if left untreated, will result in end stage renal disease. So, the relationship between atherogenic lipid profile ratios and the assessment of CKD severity is a potential area still to be explored.
I S, Siva Sankari GC, Ramaswamy V, Vasudevan A, K P.   +4 more
europepmc   +2 more sources

BMI partially mediates the association between the non-HDL-C/HDL-C ratio and depression in obese adults. [PDF]

Diabetol Metab Syndr
Depression has become one of the major global public health burdens. In recent years, lipid metabolic abnormalities have garnered increasing attention as potential influencing factors. Among these, the ratio of non-high-density lipoprotein to high-density lipoprotein cholesterol (NHHR) is regarded as an integrated indicator for assessing ...
Qiu K, Liu Y, Zhang Y, Hu C, Gu J, Huang Y.   +5 more
europepmc   +4 more sources

Role of Lipid Profile and Its Relative Ratios (Cholesterol/HDL-C, Triglyceride/HDL-C, LDL-C/HDL-C, WBC/HDL-C, and FBG/HDL-C) on Admission Predicts In-Hospital Mortality COVID-19

Journal of Lipids, 2023
Background. Lipid profile and its related ratios such as total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), triglyceride (TG), high-density lipoprotein-cholesterol (HDL-C), TG/HDL-C ratio, TC/HDL-C ratio, LDL-C/HDL-C ratio, white blood cell (WBC)/HDL-C ratio, and fasting blood glucose (FBG)/HDL-C ratio are valuable indicators that ...
Jafar Mohammadshahi, Hassan Ghobadi, Golchin Matinfar, Mohammad Hossein Boskabady, Mohammad Reza Aslani   +4 more
openaire   +2 more sources

NHHR: An Important Independent Risk Factor for Patients with STEMI

Reviews in Cardiovascular Medicine, 2022
Background: In this study, we investigated whether the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) is associated with the development of acute ST-segment elevation myocardial infarction (STEMI ...
Po Gao, Jing Zhang, Xizhen Fan
doaj   +1 more source

The effect of polyunsaturated fatty acids on cardiovascular risk factors and urinary mercury in workers employed at electrolytic production of chlorine

International Journal of Occupational Medicine and Environmental Health, 2021
Objectives While inorganic mercury is being gradually withdrawn from industry, environmental exposure to mercury is recognized as one of the greatest present toxicological problems.
Anna Skoczyńska, Maciej Cyran, Barbara Turczyn, Anna Wojakowska, Beata Smyk, Marta Skoczyńska   +5 more
doaj   +1 more source

Arginine-directed glycation and decreased HDL plasma concentration and functionality [PDF]

, 2014
Background/Objectives: Decreased plasma concentration of high-density lipoprotein cholesterol (HDL-C) is a risk factor linked to increased risk of cardiovascular disease (CVD). Decreased anti-atherogenic properties of HDL are also implicated in increased
Rabbani, Naila, Smith, L., Godfrey, L. (Lisa), Thornalley, Paul J., Yamada-Fowler, N. (Naomi)   +4 more
core   +1 more source

Phosphatidylinositol increases HDL-C levels in humans [PDF]

Journal of Lipid Research, 2005
Studies have shown that phosphatidylinositol (PI) can stimulate reverse cholesterol transport by enhancing the flux of cholesterol into HDL and by promoting the transport of high density lipoprotein-cholesterol (HDL-C) to the liver and bile. The goal of this study was to determine the safety and therapeutic value of PI after oral administration to ...
Jim W. Burgess, Tracey A-M. Neville, Patricia Rouillard, Zdena Harder, Donald S. Beanlands, Daniel L. Sparks   +5 more
openaire   +3 more sources

Effects of dalcetrapib in patients with a recent acute coronary syndrome [PDF]

, 2012
In observational analyses, higher levels of high-density lipoprotein (HDL) cholesterol have been associated with a lower risk of coronary heart disease events.
Chaitman Bernard R., Nicholls, Stephen J., Mundl, Hardi,, Ballantyne, Christie M,, Nicholls, Stephen J,, Ballantyne, Christie M., Shah, P.K., Ballantyne Christie M., Ballantyne C.M., Chaitman B.R., Wright, R Scott,, McMurray, J.J.V., McMurray, John J V, Mundl, H., Abt Markus, Shah, Prediman K., Schwartz, G.G., McMurray, John J. V., Leiter, Lawrence A,, Leiter, Lawrence A., Barter, Philip J., DE CATERINA, Raffaele, Tardif, Jean-Claude,, Barter, P.J., Leiter L.A., McMurray, J., Brumm, J., Wright, R Scott, Olsson, A.G., Abt, Markus,, Shah Prediman K., dal OUTCOMES Investigators, Leitersdorf, E., Ballantyne, C.M., Kallend, David,, Brumm, Jochen, Mundl Hardi, Shah, Prediman K,, Holme, Ingar M., McMurray, John J V,, Holme, Ingar M,, Brumm Jochen, McMurray J.J., Kallend, David, Goldner, David, Wright, R., Tardif, J., Chaitman, Bernard R,, Wright R. Scott, Shah, P., Chaitman, Bernard R., Chaitman, B., Kallend David, Nicholls, Stephen J, Schwartz Gregory G., Barter, Philip J,, Leiter Lawrence A., Tardif, Jean-Claude, Barter P.J., Barter, P., Abt, Markus, Schwartz, Gregory G., Leiter, Lawrence A, Holme I.M., Olsson, A., The dal-OUTCOMES Investigators, Tardif Jean Claude, Holme, Ingar M, Leitersdorf, Eran, Wright, R.S., Barter Philip J., Schwartz, Gregory G,, Olsson Anders G., Leiter, L.A., Olsson A.G., Olsson, Anders G., Schwartz, Gregory G, Colquhoun, David, Leiter, L., Nicholls, S.J., Barter, Philip J, Chaitman, Bernard R, Brumm, Jochen,, Leitersdorf E., Nicholls, S., Chaitman, B.R., Holme, I.M., Holme, I., Kallend, D., Brumm J., Mundl, Hardi, Shah, Prediman K, Nicholls Stephen J., Wright, R. Scott, McMurray John J. V., Kallend D., Olsson, Anders,, Ballantyne, C., Holme Ingar M., Olsson, Anders G, Abt M., Schwartz G.G., Leitersdorf Eran, Abt, M., Ballantyne, Christie M, Schwartz, G., Leitersdorf, Eran,, GOLINO, Paolo   +107 more
core   +1 more source

Data_Sheet_1_Friedewald formula may be used to calculate non-HDL-C from LDL-C and TG.ZIP

, 2023
BackgroundThe Friedewald formula (FF) was originally designed 50 years ago and has been in use to this day despite better methods for estimating LDL cholesterol (LDL-C). Its success was mainly due to its simplicity.
Jerzy Romaszko (3105870), Leszek Gromadziński (15256417), Adam Buciński (3105876)   +2 more
core   +1 more source